LT2330892T - Gydymo būdai panaudojant vaistus - amoniako gaudykles - Google Patents

Gydymo būdai panaudojant vaistus - amoniako gaudykles

Info

Publication number
LT2330892T
LT2330892T LTEP09739263.3T LT09739263T LT2330892T LT 2330892 T LT2330892 T LT 2330892T LT 09739263 T LT09739263 T LT 09739263T LT 2330892 T LT2330892 T LT 2330892T
Authority
LT
Lithuania
Prior art keywords
ammonia
treatment
methods
scavenging drugs
scavenging
Prior art date
Application number
LTEP09739263.3T
Other languages
English (en)
Inventor
Bruce Scharschmidt
Original Assignee
Horizon Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horizon Therapeutics, Inc. filed Critical Horizon Therapeutics, Inc.
Priority claimed from PCT/US2009/030362 external-priority patent/WO2009134460A1/en
Publication of LT2330892T publication Critical patent/LT2330892T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • G01N2800/085Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
LTEP09739263.3T 2008-08-29 2009-01-07 Gydymo būdai panaudojant vaistus - amoniako gaudykles LT2330892T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9323408P 2008-08-29 2008-08-29
PCT/US2009/030362 WO2009134460A1 (en) 2008-04-29 2009-01-07 Methods of treatment using ammonia-scavenging drugs

Publications (1)

Publication Number Publication Date
LT2330892T true LT2330892T (lt) 2016-11-25

Family

ID=45604478

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP16176456.8T LT3133396T (lt) 2008-08-29 2009-01-07 Gydymo būdai, panaudojant amoniaką deaktyvuojančius vaistus
LTEP09739263.3T LT2330892T (lt) 2008-08-29 2009-01-07 Gydymo būdai panaudojant vaistus - amoniako gaudykles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP16176456.8T LT3133396T (lt) 2008-08-29 2009-01-07 Gydymo būdai, panaudojant amoniaką deaktyvuojančius vaistus

Country Status (10)

Country Link
JP (3) JP5577341B2 (lt)
DK (1) DK3133396T3 (lt)
ES (2) ES2593378T3 (lt)
HR (2) HRP20161222T1 (lt)
HU (2) HUE040503T2 (lt)
LT (2) LT3133396T (lt)
PL (1) PL2330892T3 (lt)
PT (2) PT3133396T (lt)
SI (1) SI3133396T1 (lt)
TR (1) TR201816616T4 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2760479T3 (en) 2011-09-30 2017-07-17 Horizon Therapeutics Llc Nitrogen-removing drug for use in a method of treating a nitrogen retention disorder
ES2623470T3 (es) * 2012-04-20 2017-07-11 Horizon Therapeutics, Llc HPN-100 para uso en el tratamiento de trastornos de retención de nitrógeno
EP2922576B1 (en) * 2012-11-21 2017-11-08 Horizon Therapeutics, LLC Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy
TWI640327B (zh) 2013-11-14 2018-11-11 美商奧崔基尼克斯製藥公司 三酸甘油酯之固體組合物及其用途
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
JP6797456B2 (ja) * 2018-10-04 2020-12-09 アトナープ株式会社 生体情報取得システム、健康管理サーバーおよびシステム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284647A (en) * 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
ES2157422T3 (es) * 1995-02-07 2001-08-16 Brusilow Entpr Llc Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate

Also Published As

Publication number Publication date
SI3133396T1 (sl) 2018-12-31
PT3133396T (pt) 2018-12-07
ES2695534T3 (es) 2019-01-08
HUE029912T2 (en) 2017-03-28
JP2012501329A (ja) 2012-01-19
TR201816616T4 (tr) 2018-11-21
PL2330892T3 (pl) 2017-05-31
DK3133396T3 (en) 2018-12-03
PT2330892T (pt) 2016-09-05
HRP20181877T1 (hr) 2019-01-11
ES2593378T3 (es) 2016-12-09
JP2012501451A (ja) 2012-01-19
HRP20161222T1 (hr) 2017-02-10
JP2014102255A (ja) 2014-06-05
HUE040503T2 (hu) 2019-03-28
JP5577341B2 (ja) 2014-08-20
LT3133396T (lt) 2018-11-26

Similar Documents

Publication Publication Date Title
NO2016023I1 (no) Glycerol fenylbutyrat
IL208354A0 (en) Methods of treatment
IL215131A0 (en) Methods of treatment using combination therapy
IL217777A0 (en) Methods for treatment of pain
EP2521549A4 (en) THERAPEUTIC COMPOUNDS AND ASSOCIATED METHODS OF USE
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
LT3005986T (lt) Vaistų infuzija
PL2337575T3 (pl) Sposoby leczenia z użyciem pojedynczych dawek orytawancyny
ZA201000225B (en) Treatment of depression
EP2164494A4 (en) Methods of Treatment
GB0723100D0 (en) Treatment of HFnEF
EP2303284A4 (en) METHOD FOR TREATING BIPOLAR DISORDER
GB2460445B (en) Treatment of ringworm
SI2330892T1 (sl) Postopki zdravljenja z uporabo zdravil, ki odstranjujejo amoniak
EP2203432A4 (en) PROCESSING METHOD
GB0700969D0 (en) Methods of treatment
GB0819543D0 (en) Treatment of proteostatic disease
GB0817859D0 (en) Treatment of proteostatic disease
GB0823435D0 (en) Method of treatment
GB0717337D0 (en) Method of treatment
GB0803515D0 (en) Medicament and method of treatment
AU2008902372A0 (en) Methods of treatment
GB0720136D0 (en) Treatment of blood disorded
GB0804468D0 (en) Treatment of influenza
GB0802903D0 (en) Treatment of diabetes